Lobular neoplasia diagnosed at core biopsy does not mandate surgical excision
- PMID: 17662303
- DOI: 10.1016/j.jss.2007.03.052
Lobular neoplasia diagnosed at core biopsy does not mandate surgical excision
Abstract
Background: Lobular intraepithelial neoplasia (LIN) is associated with an increased risk of breast malignancy. The significance of LIN diagnosed at core needle biopsy (CNB) is unclear, although many groups recommend surgical excision to rule out lesions, which would require immediate, definitive therapy. Current management options include clinical/mammographic observation and surgical excision. The necessity of routine surgical excision remains controversial due to conflicting opinions on the biological behavior of lobular lesions, diagnostic confusion regarding histopathology, and uncertainty of their association with high-risk lesions. The purpose of this report was to review the published data regarding the incidence of high-risk lesions associated with LIN diagnosed at CNB to clarify the indications for surgical excision.
Materials and methods: A PubMed search was performed to identify all published articles in English addressing management of LIN diagnosed at CNB.
Results: The 19 studies that form the basis of this report included a total of 504 subjects. Although the studies differed greatly in their content and methods, they were analyzed as a group for the presence of criteria deemed by the authors to be the most important information to include in a study regarding this issue and thus a reasonably good indicator of the quality of the literature. All of the studies were retrospective, nearly half were nonconsecutive series, and no study reported clear inclusion criteria for surgical excision versus observation. Limitations of the reviewed studies included their retrospective nature, small number of subjects, inconsistent inclusion criteria, and selection bias regarding surgical excision.
Conclusions: Based on the reviewed literature, it is difficult to reach a firm evidence-based conclusion regarding optimal management of LIN diagnosed at CNB. Associated high-risk lesions increase the risk of upgrade, but there are no mammographic predictors. The available retrospective literature suggests that some cases of LIN are associated with higher-risk lesions identified on surgical excision but does not support routine excision for all patients.
Similar articles
-
Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?Mod Pathol. 2003 Feb;16(2):120-9. doi: 10.1097/01.MP.0000051930.68104.92. Mod Pathol. 2003. PMID: 12591964
-
Lobular neoplasia: is surgical excision warranted?Am Surg. 2008 Feb;74(2):172-7. Am Surg. 2008. PMID: 18306873 Review.
-
Lobular neoplasia on core needle biopsy does not require excision.Cancer. 2008 May 15;112(10):2152-8. doi: 10.1002/cncr.23415. Cancer. 2008. PMID: 18348299
-
Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision.Breast. 2007 Oct;16(5):533-9. doi: 10.1016/j.breast.2007.04.005. Epub 2007 Jul 12. Breast. 2007. PMID: 17629481
-
Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review.Eur J Surg Oncol. 2011 Apr;37(4):279-89. doi: 10.1016/j.ejso.2011.01.009. Eur J Surg Oncol. 2011. PMID: 21306860 Review.
Cited by
-
Prevalence, Impact, and Diagnostic Challenges of Benign Breast Disease: A Narrative Review.Int J Womens Health. 2023 May 18;15:765-778. doi: 10.2147/IJWH.S351095. eCollection 2023. Int J Womens Health. 2023. PMID: 37223067 Free PMC article. Review.
-
Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting.Cancer Med. 2014 Jun;3(3):492-9. doi: 10.1002/cam4.223. Epub 2014 Mar 18. Cancer Med. 2014. PMID: 24639339 Free PMC article.
-
Atypical lobular hyperplasia and lobular carcinoma in situ at core breast biopsy: use of careful radiologic-pathologic correlation to recommend excision or observation.Radiology. 2013 Nov;269(2):340-7. doi: 10.1148/radiol.13121730. Epub 2013 Jul 30. Radiology. 2013. PMID: 23901123 Free PMC article.
-
Distance of Biopsy-Confirmed High-Risk Breast Lesion from Concurrently Identified Breast Malignancy Associated with Risk of Carcinoma at the High-Risk Lesion Site.Cancers (Basel). 2024 Jun 19;16(12):2268. doi: 10.3390/cancers16122268. Cancers (Basel). 2024. PMID: 38927976 Free PMC article.
-
Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade.Cancer Res Treat. 2022 Oct;54(4):1074-1080. doi: 10.4143/crt.2021.864. Epub 2021 Dec 21. Cancer Res Treat. 2022. PMID: 34942684 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical